ELISA
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site....
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Other uncategorised cookies are those that are being analysed and have not been classified into a category as yet.
ELISA
Dash’s ELISA platform delivers highly consistent, flexible, and scalable assay execution with unmatched speed and quality. With integrated plate washing, reading, incubating, and shaking, we efficiently execute ELISA assays to support critical applications such as PK, PD, ADA, biomarker analysis, and cytokine panels.
Our platform is optimized for ELISA readouts in both 96- and 384-well plate formats. We offer development of fully custom ELISA assays, rapid implementation of existing vendor kits, and pre-developed ELISA kits for common analytes, including multiplex cytokine panels.
Dash is deeply experienced in end-to-end ELISA assay development, optimization, and high-throughput execution. Our scientists bring extensive expertise across therapeutic areas and sample types, enabling us to tailor workflows for even the most complex study designs. From exploratory biomarker discovery through late-stage clinical support, we deliver actionable, reproducible ELISA data that accelerate decision-making and de-risk development programs.
Accelerated ELISA Assay Execution with a Highly Automated Bioanalysis CRO
At Dash Bio, we specialize in delivering ELISA assay services with unmatched speed, sensitivity, and precision. As a highly automated bioanalysis CRO, we streamline every stage of ELISA assay development and execution—from sample intake to data delivery—so you can accelerate decision-making and keep your development programs on track.
Our automation-first approach to ELISA assays ensures consistency, reproducibility, and dramatically shortened timelines for the studies that matter most. Whether you are measuring biomarkers, evaluating large molecule pharmacokinetics (PK), conducting ADA testing, or analyzing small molecule drug candidates, our ELISA platforms are optimized to deliver high-quality, reliable results with industry-leading turnaround times. By integrating robotics, advanced liquid handling, and intelligent workflows, we remove bottlenecks that slow traditional CROs, enabling your team to access critical data faster.
With deep expertise in ELISA assay development and bioanalysis CRO services spanning early discovery through clinical development, Dash Bio understands the unique requirements of ELISA-based biomarker assays across therapeutic areas. Our scientists bring rigor and scalability to every project, leveraging multiplexing capability, sensitive detection, and automated precision to deliver results that are not only faster, but also more reproducible and trustworthy.
When timelines are critical, you need a partner who can combine scale with quality. Dash Bio is redefining the standard for ELISA assay execution by pairing assay development expertise with next-generation automation. The result: a proven solution to accelerate studies, de-risk development pipelines, and keep your programs advancing at the pace of innovation.